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ABSTRACT 
 
THE ASSOCIATION BETWEEN PERIODONTAL DISEASE AND METABOLIC SYNDROME AMONG 
UNITED STATES ADULTS: ANALYSIS OF NHANES 2013-2014. 
By 
 
BRENDA RUIZ 
 
APRIL 2019 
 
INTRODUCTION:  Studies support a bidirectional relationship between periodontal disease and 
metabolic syndrome (MetS). In addition to sharing risk factors, it is believed they also share a 
pathologic role in the development or progression of cardiovascular disease (CVD). The present 
article presents an overview of the evidence linking periodontitis with selected systemic diseases 
and calls for increased cooperation between medical and oral healthcare providers to provide 
optimal screening, treatment, and prevention of both periodontitis and its comorbidities. 
AIM: This study aims to understand (a) the relationship between periodontal disease and 
metabolic syndrome and (b) the associations between periodontal disease and the components 
comprising metabolic syndrome (hypertension, reduced HDL cholesterol levels, elevated 
triglyceride levels, abdominal obesity, and elevated blood glucose levels) using the National 
Health and Nutrition Examination Survey data. 
METHODS: A cross-sectional analysis of the 2013-2014 National Health and Nutrition 
Examination Survey (NHANES) data was conducted to assess the associations between 
periodontal disease, metabolic syndrome, and the components comprising metabolic syndrome. 
Participants aged ≥30 years were eligible. Periodontal disease was defined using the Centers for 
Disease Control and Prevention- American Academy of Periodontology (CDC-AAP) guidelines and 
metabolic syndrome was defined using the International Diabetes Federation (IDF) criteria. The 
adjusted odds ratios of periodontal disease ware calculated controlling for variables fitted using 
logistic regression. Data were assembled and analyzed using SAS 9.4 (Statistical Analysis System, 
Cary, NC, USA). 
RESULTS:  For both MetS and periodontal disease, statistically significant associations were 
observed in all of the selected participant demographic characteristics. Despite existing evidence 
suggesting a bidirectional relationship between periodontal disease and MetS, and positive 
associations between periodontal disease and the five metabolic risk factors that comprise MetS, 
no statistically significant associations could be determined in this analysis. 
DISCUSSION: The purpose of this analysis was to explore the associations between periodontal 
disease, MetS, and the five metabolic risk factors (hypertension, reduced HDL cholesterol, 
abdominal obesity, elevated blood glucose levels, and elevated triglycerides) among the United 
States’ adult population. By understanding the risk factors associated with systemic diseases we 
are able to better target at-risk population groups, improve health and healthcare, and advance 
health equity. 
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Chapter I-Introduction 
1.1 Background 
In the United States today, chronic diseases are among the most prevalent and costly 
health conditions, leading to hospitalization, long-term disability, reduced quality of life, and 
death.1-4  Despite having relatively poor health outcomes; the US, leads in health care spending. 
This is largely due to the rising number of Americans living with chronic diseases.1,2 There are a 
number of factors driving the increase in people living with chronic medical conditions. A lack of 
universal health insurance and poor access to primary care contribute to inadequate prevention, 
detection, and management of chronic diseases. At the same time, an aging and increasingly 
overweight and obese population, in part due to social, economic, and environmental factors 
that create barriers to affordable healthy lifestyle choices have also enabled more sedentary and 
unhealthy behaviors, furthering the rise in chronic diseases.5  According to the Centers for 
Disease Prevention and Control (CDC), the current burden of six in ten Americans suffering from 
at least one chronic disease is expected to rise as competing priorities, limited resources, and 
misuse and overuse of medical care continue to drive the prices of labor, pharmaceuticals, and 
administrative costs upward.3 
Cardiovascular disease (CVD) is one of the most prevalent chronic diseases affecting 
Americans and the leading cause of death worldwide.6,7 CVD includes a range of disorders that 
affect the body’s blood vessels and the heart’s structure and function.7 Risk factors for CVD 
include hypertension, abnormal cholesterol levels, and elevated blood glucose levels. One clearly 
identified  cluster of conditions that increases the risk of CVD is called metabolic syndrome 
(MetS).8  
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MetS includes five core components, all of which are known metabolic risk factors for 
CVD. These include: abdominal obesity,a elevated triglycerides,b reduced HDL cholesterol,c 
hypertension,d and elevated fasting blood glucose.e, 9,1S0 What is particularly alarming about MetS 
is that in addition to increasing the risk of CVD, each component of this syndrome also increases 
the risk for progression of other chronic diseases like type 2 diabetes, results in deteriorating 
disabilities, and poses an indirect economic burden, among others.11,12 According to the CDC, the 
prevalence of MetS is estimated at greater than 30% in the U.S. and has substantially increased 
since 1988.11-13 Other risk factors associated with MetS and increased risk of CVD include oral 
diseases, and more specifically periodontal disease.14,15 
 Periodontal disease, a condition found in over 47% of U.S. adults, is strongly associated 
with risk for CVD, independent of traditional CVD risk factors.14,15 Periodontal disease or 
periodontitis is a chronic inflammatory condition of the gums, caused by naturally-occurring 
bacteria found in the mouth.16  Like other biofilm infections,f it is resistant to antibiotic agents 
and host defenses due to the complex communities the microbes form. Without treatment and 
adequate preventive care, periodontitis affects the bone and supporting tissue, leading to the 
formation of pockets or spaces between the teeth and gums, that eventually lead to sore, 
bleeding gums, temporomandibular joint (TMJ) disorders, premature tooth loss, and other health 
conditions.16,17 Several reports have shown that treating the symptoms of periodontitis and 
managing its progression have helped with the management of other chronic conditions, 
                                                          
a Abdominal obesity: Waist circumference ≥ 102 cm in males or ≥ 88 cm in females 
b Elevated Triglycerides: ≥ 150 mg/dL  
c Reduced HDL Cholesterol: reduced HDL cholesterol: < 40 mg/dL in males or < 50 mg/dL in females 
d Hypertension: Systolic BP ≥ 130 or diastolic BP ≥ 85 mm Hg 
e Elevated fasting plasma glucose: (FPG) ≥ 100 or oral glucose tolerance test (OGTT) ≥ 100 mg/dL 
f Biofilm Infection: a thin, slimy film of bacteria that adheres to a surface 
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including diabetes, heart disease, osteoporosis, respiratory disease and cancer.17 Because 
periodontal care is not commonly covered under health insurance, preventive care and early 
treatment is often delayed. As a result, periodontitis may go undetected until symptoms worsen 
in advanced stages.14-17 
There is increasing recognition of the important relationship between different chronic 
diseases and that they do not exist in isolation.3 This is especially true for the relationships 
between oral health and physical health. Improving our understanding of these relationships is 
critical to informing both preventive approaches and integrating oral health care strategies into 
chronic disease prevention and management.   
 
1.2 Research Aims and Hypotheses 
 This research will evaluate the extent to which metabolic syndrome and the five 
metabolic risk factors comprising MetS are associated with periodontal disease in the U.S. adult 
population using data collected from the 2013-2014 National Health and Nutritional Examination 
Survey (NHANES). 
       This study aims to understand:  
Aim 1: Assess the association between metabolic syndrome and periodontal disease. 
Hypothesis 1: There will be statistically significant associations between metabolic syndrome and 
periodontal disease. 
Aim 2: Assess the associations between each of the conditions that comprise metabolic syndrome 
(hypertension, reduced HDL cholesterol, abdominal obesity, elevated triglyceride, and blood 
glucose levels) and periodontal disease. 
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Hypothesis 2: There will be statistically significant associations between periodontal disease  
hypertension, reduced HDL cholesterol, abdominal obesity, elevated triglyceride, and elevated 
blood glucose levels. 
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Chapter II-Literature Review 
2.1 Periodontal Disease and MetS 
Although largely preventable, dental caries and periodontal disease pose the greatest 
threat to oral health, and are among the most prevalent chronic diseases in the U.S.18,19 Without 
timely and appropriate treatment, they can result in complications including, oral pain, 
dysfunction, abscess formation, premature edentulism, and others.18 Evidence of possible 
associations between chronic oral infections and systemic disorders is widely supported, such 
that, the association between periodontal disease and systemic disorders has led to the evolution 
of periodontal medicine.g,18,20,21 
Studies support a bidirectional relationship between periodontal disease and MetS. In 
addition to sharing risk factors, it is believed they also share a pathologic role in the development 
or progression of CVD.7,8,10,20,22-29 In a cohort study conducted by Morita et al., of 1,023 adult 
employees who were followed for 4 years, they demonstrated a significant association between 
the presence of periodontal pockets and the development of one or more MetS components (OR: 
1.6; 95% CI: 1.1 to 2.2).22 In another study, using a nationally representative sample, D’Aiuto et 
al. observed that the diagnosis of MetS increased among individuals with periodontal disease.23 
Moreover, the results showed a significant association between the severity of periodontal  
disease and the likelihood of also having MetS.23 The prevalence of MetS was 18% (95% CI: 16-
19) in those with no/mild periodontitis compared with 37% (95% CI: 28-48) in those with severe 
periodontitis.23 A longitudinal study by Nesbitt et al., also demonstrated the association between 
                                                          
g Periodontal Medicine: a branch of medicine dedicated to the study of the dynamic relationship between 
periodontal diseases and systemic conditions  
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periodontal disease and MetS; participants with periodontal disease were significantly more 
likely to possess components of MetS (OR 2.61, 95% CI 1.1-6.1, p<0.05).25 
Studies also support the relationship between the severity of periodontal disease and the 
degree of MetS. In a multivariate analysis of 584 Japanese women, persons exhibiting more 
components of MetS had a significantly higher likelihood of having a greater pocket depth and 
clinical attachment loss— indicating more severe periodontal disease— than those with no 
components.26 In a European study with 2,050 participants, MetS was associated with deepened 
periodontal pockets and carious teeth.27,28 In addition, a study of 941 adolescents suggested 
MetS components may be determinants for future periodontal diseases.29 Based on the study 
results, having more components of MetS showed a significant positive correlation with gingivitis 
and other periodontal problems.29 Those with one component of MetS had an OR of 1.88(95% 
CI: 1.28–2.76), compared with 3.29 (95% CI: 1.24–8.71) in those with three or more MetS 
components.29  
Research also demonstrates that MetS and periodontal disease  are linked through a 
common pathophysiological pathway. A meta-analysis by Lamster and Pagan evaluated the 
evidence regarding this relationship.8 Their review found that both conditions can be attributed 
to oxidative stress, resulting in a low grade systemic inflammatory condition and increasing the 
risk of CVD.8 According to the study, individuals with periodontal disease, MetS, or a combination 
of both showed elevated levels of circulating inflammatory markers. These findings are further 
supported by additional studies that implicate inflammatory cytokines and other mediators 
produced in the periodontal lesion in regard to their capacity to impact tissues and organs distant 
from the oral cavity.20,30-35 Systemic disorders associated with the inflammatory response 
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include; diabetes mellitus, myocardial infarction, and endothelial dysfunction, among others.30-
35  
In addition to the relationship between periodontal disease and MetS, research also 
indicates that there are relationships between periodontal disease and the individual metabolic 
risk factors that make up MetS, as discussed below. 
 
2.2 Periodontal Disease and Abdominal Obesity  
Obesity is characterized by abnormal or excessive deposition of fat in the adipose tissue 
and is a chronic disease with a multi-factorial etiology.20,36 If unaddressed, obesity can lead to 
adverse health outcomes and the secretion of cytokines and hormones involved in the 
pathophysiology of related systemic diseases.36 For instance, prevailing data suggests that both 
obesity and MetS are immediate precursors of diabetes mellitus and CVD.20, 30-35 Now, further 
evidence suggests obesity is involved in regulating the onset and progression of periodontitis, 
due to the impact it generates on the metabolic and immune parameters of the host.20,35-39 Juárez 
et al., performed a multivariate analysis of 136 participants and found that 62.3% had both 
periodontal disease and obesity.37 Moreover, the participants with abdominal obesity had 2.4 
times greater odds of having periodontal disease (95% CI: 1.01-5.1).37  Similar results were 
obtained in a case-control study by Suvan et al.; participants showed increased odds of diagnosis 
of periodontitis if they were overweight (OR = 2.56, 95% CI 1.210-5.400) or obese  (OR = 3.11, 
95% CI 1.052-6.481), compared to normal weight individuals.38 Furthermore, a systematic review 
investigating the association between obesity and periodontal disease also showed consistent 
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results, with a pattern of increased risk of periodontitis among overweight and obese 
individuals.39 
 
2.3 Periodontal Disease and Hyperlipidemia 
Like obesity, hyperlipidemia, is a component of MetS associated with both periodontal 
disease and an increased risk of CVD.40 Hyperlipidemia refers to abnormal levels of cholesterol 
and triglyceride in the blood including hypertriglyceridemia (elevated triglycerides), elevated LDL 
cholesterol, and reduced HDL cholesterol.40 Studies reveal a significant bi-directional relationship 
between periodontitis and elevated triglycerides, reduced HDL cholesterol, and elevated LDL 
cholesterol levels.40-45 In a sample size of 33,000 individuals, those with periodontitis had 
significantly increased odds for having elevated triglycerides in both male and female subjects.41 
Similarly, results by Morita et al. and Sandi et al. found that individuals with elevated triglycerides 
were much more likely to have periodontal pockets.20,22,42 A case-control study conducted in Iran,  
further supported these findings, as results showed triglyceride levels were significantly higher 
in periodontal disease patients compared to healthy subjects.43 Elevated levels of serum 
cholesterol and LDL were also associated with greater odds of periodontal disease.42-45 The 
findings of Sandi et al., support this assumption, as patients with chronic periodontitis showed 
increased serum cholesterol and LDL levels.42 Another observational study supported this 
association, also showing that patients with periodontal disease had reduced levels of HDL and 
elevated levels of LDL.45  Last, in a separate study, low HDL cholesterol was the only MetS 
component significantly associated with the serum antibody for Porphyromonas gingivalis, a 
marker for periodontal disease.44  
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2.4 Periodontal Disease and Hypertension 
Hypertension is one of the most important risk factors for CVD and the most common 
component of MetS.22, 31,34,46,47 Both oxidative stress and endothelial dysfunction are among the 
critical pathways in the development of hypertension, however, inflammation has increasingly 
become a recognized contributor.46 Many cross-sectional studies propose that the inflammatory 
response accompanying periodontitis is an important factor that may exert adverse effects on 
the regulation of blood pressure.46,47 Recent studies have shown that both systolic and diastolic 
blood pressures are higher among periodontal patients than in individuals without periodontitis 
however, the associations are weaker compared to other MetS components.48 According to 
research by Morita et al., blood pressure was least strongly associated with the presence of 
periodontal pockets of the five core components of MetS , however the association was still 
significant.20 Moreover, The Oral Infections and Vascular Disease Epidemiology Study (INVEST) 
showed a direct relationship between the levels of subgingival periodontal bacteria and 
hypertension prevalence; the odds ratio for prevalent hypertension was 3.05 (95% CI: 1.60-
5.82).49 Furthermore, in a study that analyzed data from the Third National Health and Nutrition 
Examination Survey, a positive linear relationship was demonstrated between systolic BP and 
severe periodontitis in middle-aged individuals, giving further strength to the association 
between periodontal disease and hypertension.50 
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2.5 Periodontal Disease and Dysglycemia 
According to multiple studies, dysglycemiah shows the most well-established relationship to 
periodontal disease.8,21,22,51-53 Epidemiological data confirm susceptibility to periodontitis is 
increased by approximately threefold in people with diabetes.51 Furthermore, there is emerging 
evidence to suggest the existence of a two-way relationship between diabetes and periodontitis, 
with diabetes increasing the risk for periodontitis, and periodontal inflammation negatively 
affecting glycemic control.51 In a study of 1,097 subjects, individuals with diabetes mellitus or 
pre‐diabetes had a greater prevalence of periodontal pockets and missing teeth, compared with 
subjects with normoglycemia.52 Furthermore, Morita et al. observed that individuals with 
elevated fasting plasma glucose and elevated glycosylated hemoglobin levels (a longer-term 
glucose marker) had increased odds of periodontitis (OR = 1.9 and OR=2.0, respectively).22 The 
results of a 7 year prospective study assessing the effect of periodontitis on diabetes incidence 
were supportive of previous findings; specifically,  moderate and severe periodontitis were 
significantly associated with an increased risk of diabetes.53 Furthermore, in a prospective cohort 
study, type 2 diabetic individuals with severe periodontal disease had 3.2 times the risk of 
mortality due to ischemic heart disease compared to individuals with no or mild periodontal 
disease.21 Based on study findings, improving glycemic control is likely to reduce the risk and 
severity of periodontitis in addition to being clinically relevant in the management of related 
systemic diseases like diabetes.  
 
 
                                                          
h Dysglycemia: broad term referring to an abnormality in blood sugar stability 
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2.6 Periodontal Therapy and Systemic Disease 
Over the last few decades, the association between periodontal disease and MetS has 
garnered considerable interest among the scientific and medical community. Evidence suggests 
that periodontal therapy in individuals exhibiting MetS has the potential to reduce the levels of 
inflammatory mediators in serum and prevent various adverse systemic complications.20,21,30-
34,53-58 Periodontal therapy involves the removal of plaque and calculus (tartar) by both surgical 
and non-surgical processes to help restore health to the tissues that support the teeth.54 Studies 
show that periodontal therapy may improve glycemic control and lipid profiles in type 2 diabetics 
by reducing glycosylated hemoglobin levels.30-34,53-58 Moreover, a bidirectional relationship is 
proposed, such that, treatment of diabetes may actually improve periodontal status. 30-34,53-58 A 
prospective cohort study of 628 subjects revealed type 2 diabetic individuals with severe 
periodontal disease had a 3.2 times greater mortality risk compared with individuals with no or 
mild periodontitis.21 In a randomized controlled trial of periodontal patients assigned to different 
periodontal therapies, systolic blood pressure (p < .05) and triglycerides (p < .05) were 
significantly reduced overall.59 Moreover, the number of participants that met the requirements 
for MetS (27%) was reduced to 14.5%, 17.3%, and 21.8%  at three months, six months, and twelve 
months respectively, post-therapy.5 
2.7 Periodontal Disease and General Wellness 
Periodontal medicine has allowed for further investigation of the association between 
periodontal disease and MetS, and the demand for increased cooperation between dentists and 
medical doctors to provide optimal screening, treatment, and prevention of both periodontitis 
and its comorbidities.31 Present studies display a coherent relationship between periodontitis 
12 
 
and MetS, such that, subjects displaying several components of MetS should be referred for 
periodontal examination, and those with periodontal disease should be evaluated for MetS and 
its underlying conditions.18,19 Integrated clinical care would potentially improve both oral and 
general health outcomes.8,18  
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Chapter III-Methodology 
3.1 Study Design 
A cross-sectional analysis was conducted on the U.S. adult population to explore the 
association between periodontal disease, MetS, and each component of MetS. The sample 
population was derived from a secondary database, the  2013-2014 National Health and Nutrition 
Examination Survey (NHANES); which uses complex and multi-stage, probability sampling to 
select participants representative of the civilian, and non-institutionalized U.S. population.61 
Oversampling of certain population subgroups was also done to increase the reliability and 
precision of health status indicator estimates for these groups.61  
The 2013-2014 NHANES survey was selected as the database of choice because it is the 
most recent survey completed with an oral health exam and full periodontal examination. Oral 
health data collection protocols were approved by the Centers for Disease Control and 
Prevention (CDC), National Center for Health Statistics, National Center for Chronic Disease 
Prevention and Health Promotion, and National Institute of Dental and Craniofacial Research. 62 
Moreover, the periodontal assessment and questionnaire were developed in collaboration with 
the American Academy of Periodontology (AAP) and the Centers for Disease Control Periodontal 
Disease Surveillance Workgroup.62 
All periodontal examinations were conducted in a mobile examination center (MEC) by 
licensed dentists in 2013–2014, and data were recorded separately by a separate dental 
recorder. 
The technical details of the survey, including sampling design, periodontal data collection 
protocols, and data availability can be accessed at: www.cdc.gov/nchs/nhanes.htm.- 
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The oral health questionnaire used to assess subjects can be retrieved from: 
https://wwwn.cdc.gov/nchs/data/nhanes/2013-2014/questionnaires/OHQ_H.pdf,  
while the details of the oral health procedures conducted can be found: 
https://wwwn.cdc.gov/nchs/data/nhanes/2013-2014/manuals/Oral_Health_Examiners.pdf. 
Data assembly was accomplished using SAS 9.4 (Statistical Analysis System, Cary, NC, USA). 
Eligibility Criteria  
Adults ≥ 30 years of age who participated in the 2013-2014 NHANES were included in the 
study. Due to the potential risks associated with a full-mouth periodontal examination, 
participants with conditions that are associated with the highest risk of adverse outcome from 
endocarditis as identified by the American Dental Association in partnership with the American 
Heart Association, were excluded.62  
 
Defining Periodontal Disease 
For the purposes of epidemiological research, periodontal disease is defined very 
specifically using the CDC-AAP guidelines.  Case definitions for surveillance consider two types of 
clinical periodontal measurements: attachment loss and pocket depth. For this study, the 
prevalence of periodontal disease was determined in persons with at least one periodontal site 
with 3 millimeters or more of calculated attachment loss and 4 millimeters or more of pocket 
depth (excluding all 3rd molars).64 For the NHANES periodontal examination, examiners made 
two measurements at each periodontal site: one for gingival recession (distance between the 
free gingival margin and the cementoenamel junction) and the second for probing pocket depth 
(distance from the free gingival margin to the bottom of the sulcus or periodontal pocket). 
15 
 
Calculated attachment loss was achieved using the difference between gingival recession and 
probing pocket depth.62-65  
 
Defining Metabolic Syndrome and the Metabolic Risk Factors 
The International Diabetes Federation (IDF) criteria were used to determine the 
prevalence of MetS. These criteria were selected because they address both clinical and research 
needs and provide a comprehensive list of criteria including ethnic specific cut-off points. 
According to the IDF definition, to be diagnosed as having MetS, a person must have central 
(abdominal) obesity together with any two of the following risk factors: elevated triglycerides, 
reduced HDL cholesterol, elevated blood pressure, or elevated fasting plasma glucose.11 
Central obesity and reduced HDL cholesterol status was determined for male participants 
if they had a waist circumference ≥ 102 cm and an HDL cholesterol reading of < 40mg/dL; for 
female participants, they were required to have a waist circumference  ≥ 88 cm and an HDL 
cholesterol reading of < 50mg/dL. Elevated triglyceride status was determined for any participant 
having triglycerides ≥ 150 mg/dl or specific treatment for this lipid abnormality. Elevated blood 
pressure was determined for any participant with an average systolic blood pressure reading ≥ 
130 or a diastolic blood pressure ≥ 85 mm Hg or treatment of previously diagnosed hypertension. 
Elevated fasting plasma glucose (EFG) status was determined for any participant with a fasting 
plasma glucose (FPG) ≥ 100 mg/dL or an oral glucose tolerance test (OGTT) ≥ 100 mg/DL or 
previously diagnosed type 2 diabetes. 
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Categorizing Participant Characteristics 
Age was reported as the age in years at the time of participation. Participants were 
distributed across three age categories: adults (30-45) years, middle-aged (46-65) years, and 
seniors (65 years or greater). 
Gender of the participants was reported as the self-reported identification at the time of 
the screening. 
Race/ Ethnicity was classified into four categories: (1) Non-Hispanic White, (2) Hispanic, 
(3) Non-Hispanic Black and (4) Other. The “Hispanic” category combined Mexican-American and 
other Hispanic populations as one group, while the “Other” category combined multi-racial and 
other populations as one group. 
Education was classified into three categories: (1)  less than high school or high school 
graduate equivalent, (2) greater than high school and some college, and (3) college graduate or 
greater.  Those with an associate degree were included in in the “greater than high school and 
some college” category while those with a bachelor’s degree or greater were included in the 
“college graduate or greater”  category. 
Poverty to income ratios status was based on family income relative to the poverty 
threshold and used to measure socioeconomic status. Based on the Federal Poverty Guidelines 
for 2014, participant’s poverty-to-income ratio was classified into three categories: (1) <1.00, (2) 
1.00-4.00, and (3) >4.00.66 Participants with a ratio of 1.00 have an income below the federal 
poverty level, participants with a ratio between 1.00-4.00 have low-middle incomes, and those 
above 4.00 have middle-upper incomes. 
17 
 
Insurance status of participants was self-reported as “yes” or “no” to the question: “Are 
you covered by health insurance or some other kind of health care plan-includes health insurance 
obtained through employment or purchased directly as well as government programs like 
Medicare and Medicaid that provide medical care or help pay medical bills?” 
 
3.2 Statistical Analysis 
In the 2013-2014 NHANES, 14,332 persons were selected to participate from 30 different 
survey locations. Of those selected, 10,175 completed the interview and 9,813 were examined.67 
For the requirements of this analysis and after applying MEC examination weights, to adjust for 
the effects of the sampling design, including the unequal probability of selection, the total sample 
consisted of 1,813 participants.  
Descriptive statistics were conducted for selected demographic participant 
characteristics (age, gender, race/ethnicity, education, poverty-to-income ratio, health insurance 
status) and clinical measurements (body waist circumference, fasting plasma glucose, blood 
pressure, triglyceride levels, HDL cholesterol level, periodontal disease, MetS) and bivariate 
analyses were conducted using Chi-Square Test for categorical variables and the Wilcoxon Rank 
sum test for continuous variables. Moreover, multivariable logistic regression models were 
constructed to explore the relationship between body waist circumference, fasting plasma 
glucose, blood pressure, triglycerides, cholesterol, periodontal disease, MetS and periodontal 
disease. The results for the logistic regression models were reported as odd ratios (OR) along 
with their respective 95% confidence interval (CI). The final models (6 total) were fitted by 
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potential confounders identified by the bivariate analysis. The significance of prevalence 
differences and odds ratios were assessed with an alpha level of 0.05. 
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Chapter IV-Results 
4.1 Descriptive Statistics 
 In total, 1,813 participants were eligible for the study. Of the total 1,813 participants, 
1,109 had information for periodontal disease and 1,761 for MetS; participants with missing data 
on the variable of interest were excluded in the analysis. 
Periodontal Disease Characteristics 
 Of the eligible participants, 608 (50.62%) had periodontal disease while the remaining  
501 (49.38%) did not have the disease. Among these, 50.18% were female and 49.82% were 
male.  Periodontal disease prevalence was highest among seniors (aged 65+) , followed by 
middle-aged adults (aged 46-65), and adults ages 30 to 45. Moreover, the prevalence of 
periodontal disease was highest among racial and ethnic minorities (non-Hispanic Blacks, 
Hispanics, and other, respectively), those with an education less than or equivalent to high school 
(71.36%), those with a poverty to income ratio < 1.00 (65.62%), and those with no health 
insurance (65.33%). In addition, the prevalence of periodontal disease was found to be greater 
in participants having central obesity (50.17%), elevated fasting plasma glucose (51.39%), 
elevated blood pressure (54.71%), reduced HDL cholesterol (52.06%), and metabolic syndrome 
(50.34%). 
 
Metabolic Syndrome Characteristics 
 In contrast to periodontal disease, the majority of participants (994, 57.12%) did not have 
MetS compared to those who did (767, 42.88%). Among these, 48.06% were female and 51.94% 
were male.  The prevalence of MetS was highest among seniors (aged 65+), followed by middle-
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aged adults (aged 46-65), followed by adults ages 30 to 45. The prevalence of MetS was highest 
among non-Hispanic Whites (45.31%), followed by non-Hispanic Blacks (43.33%), followed by 
Hispanics (39.99%), followed by other races (23.55%). Among those with an education greater 
than high school/some college(49.00%), a poverty to income ratio between 1.00 and 4.00 
(47.26%), health insurance (45.07%) and periodontal disease(40.67), the prevalence of MetS was 
also the highest. 
4.2 Result of Bivariate Analysis 
Periodontal Disease and Participant’s Characteristics  
 Statistically significant associations were found between periodontal disease and all the 
selected participant demographic characteristics including age (P<.0001), gender (P=0.001), 
race/ethnicity (P<.0001), education (P<.0001), poverty-to-income ratio (P<.001), and health 
insurance (P<.0001). In contrast, the only component of MetS that had a statistically 
significant association determined with periodontal disease was elevated blood pressure 
(P=0.0035) (See Tables 1.1 and 1.2). 
Metabolic Syndrome and Participant’s Characteristics  
 Statistically significant associations were found between MetS and all selected participant 
demographic characteristics: age (P<.0001), gender (P=0.0077), race/ethnicity (P<.0001), 
education (P<.0001), poverty-to-income ratio (P=0.0047), and health insurance (P=0.0013). 
However, the association between MetS and periodontal disease was not significant (P=0.6334) 
(See Table 1.3). 
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4.3 Result of Multivariate Analysis 
Unadjusted Odds Ratios 
In the unadjusted models, under replicated and identical studies: The odds of observing 
periodontal disease in the population aged 65+ is 2.976 the odds of observing periodontal disease 
in the population aged between 30 and 45;  95% of the time, the odds ratio will be between 
1.958-4.522. The odds of observing periodontal disease in the men is 1.573 the odds of observing 
periodontal disease in women; 95% of the time, the odds ratio will be between 1.201-2.059. The 
odds of observing periodontal disease in non-Hispanic Blacks is 2.309 the odds of observing 
periodontal disease in non-Hispanic Whites; 95% of the time, the odds ratio will be between 
1.354-3.938. The odds of observing periodontal disease among those with ≤ high school is 3.791 
the odds of observing periodontal disease in those with an education > college;  95% of the time, 
the odds ratio will be between 2.484-5.784. The odds of observing periodontal disease among 
those with a poverty-to-income ratio <1.00 is 1.915 the odds of observing periodontal disease in 
those with a poverty-to-income ratio ≥ 1.00-4.00; 95% of the time, the odds ratio will be between 
1.218-3.011. The odds of observing periodontal disease among those with a poverty-to-income 
ratio >4.00 is 0.765 the odds of observing periodontal disease in those with a poverty-to-income 
ratio ≥ 1.00-4.00; 95% of the time, the odds ratio will be between 0.605-0.968. The odds of 
observing periodontal disease among those with no health insurance is 2.177 the odds of 
observing periodontal disease in those with health insurance; 95% of the time, the odds ratio will 
be between 1.413-3.353. (See Tables 1.1 and 1.2). 
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Adjusted Odds Ratios 
In the adjusted models, under replicated and identical studies and controlling for age, 
gender, race/ethnicity, education, poverty-to-income ratio, and health insurance: The odds of 
observing periodontal disease in centrally obese participants is 1.045 the odds of observing 
periodontal disease in non-centrally obese participants; 95% of the time, the odds ratio will be 
between 0.791-1.379. The odds of observing periodontal disease in participants with elevated 
fasting plasma glucose is 0.835 the odds of observing periodontal disease in participants with 
normal elevated fasting plasma glucose; 95% of the time, the odds ratio will be between 0.522-
1.534. The odds of observing periodontal disease in participants with elevated blood pressure is 
1.172 the odds of observing periodontal disease in participants with normal blood pressure; 95% 
of the time, the odds ratio will be between 0.821-1.674. The odds of observing periodontal 
disease in participants with elevated triglycerides is 0.835 the odds of observing periodontal 
disease in participants with normal triglycerides; 95% of the time, the odds ratio will be between 
0.550-1.269. The odds of observing periodontal disease in participants with reduced HDL 
cholesterol is 0.984 the odds of observing periodontal disease in participants with normal HDL 
cholesterol; 95% of the time, the odds ratio will be between 0.571-1.697. The odds of observing 
periodontal disease in participants with MetS is 0.885 the odds of observing periodontal disease 
in participants with no MetS; 95% of the time, the odds ratio will be between 0.607-1.288 (See 
Table 2.1). 
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Chapter V-Discussion 
5.1 Discussion 
The purpose of this analysis was to explore the associations between periodontal disease, 
MetS, and the five metabolic risk factors (hypertension, reduced HDL cholesterol, abdominal 
obesity, elevated blood glucose levels, and elevated triglycerides) among the United States adult 
population. To be diagnosed with MetS, one must have had at least three of the five metabolic 
risk factors (defined by the IDF criteria), and to be diagnosed with periodontal disease, one must 
have had at least one periodontal site with 3 millimeters or more of calculated attachment loss 
and 4 millimeters or more of pocket depth (excluding all 3rd molars). 9-11,64 The results of this 
analysis suggest limited and inconclusive evidence for the associations of interest.  
For both MetS and periodontal disease, statistically significant associations were 
observed in specific participant demographic characteristics. These findings are consistent with 
previous studies showing that the prevalence of periodontitis ranked highest among racial and 
ethnic minorities, men, adults aged 65 and older, and those with less than a high school 
education.14,19 The added elements of health insurance and poverty-to-income ratio gave insight 
to the potential impact socioeconomic status has on health outcomes, by also yielding 
statistically significant associations with lack of health insurance and lower income levels. In “Oral 
Health: The Silent Epidemic,” former U.S. Surgeon General Regina Benjamin reports that a 
striking 25% of adults ages 65 and older have lost all of their teeth due to untreated oral disease, 
and that health disparities related to access to proper dental care may be responsible.18 
According to the data from Dr. Benjamin, oral health diseases disproportionately affect 
disadvantaged communities.18,69-71 Moreover, the findings of this study are also consistent with 
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previous analyses showing that oral health and dental disease are closely associated with income 
and education.18.19,69-71  
Despite existing evidence to suggest a bidirectional relationship between periodontal 
disease and MetS, and positive associations between periodontal disease and the five metabolic 
risk factors, no statistically significant associations were demonstrated in this analysis.21 These 
findings are not consistent with previous research, suggesting differences may be subject to 
systemic error and variable selection. For instance, the defining criteria for metabolic syndrome 
may have been too selective compared to other studies and the defining criteria for periodontal 
disease may have been too vague. Moreover, perhaps the associations become statistically 
significant when considering the extent or severity of periodontal disease.19 The only significant 
association observed was between periodontal disease and hypertension, which has been 
demonstrated to be relevant, however, weaker, compared to other MetS components.48  
While the associations between hypertension, reduced HDL cholesterol, abdominal 
obesity, elevated blood glucose levels, elevated triglycerides and periodontal disease in this 
analysis were not statistically significant, it is important not to overlook that both the outcome 
and predictors were significantly associated with age, gender, race/ethnicity, education level, 
poverty-to-income ratio, and health insurance status. These results imply that while no evidence 
was found to support a link between periodontal disease and metabolic syndrome or periodontal 
disease and the five metabolic risk factors, they are strongly associated with socioeconomic 
status. These findings emphasize the prevalence of health disparities among populations with 
lower socioeconomic status, and the importance of targeting resources and interventions to 
these communities of greatest need. 
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5.2 Study Limitations 
Due to the cross-sectional nature of the study, this analysis has several limitations. For 
instance, we are unable to infer causal relationships  because the presence of risk factors (MetS, 
hypertension, reduced HDL, abdominal obesity, elevated blood glucose levels, elevated 
triglycerides) and outcome (periodontal disease) were measured simultaneously . Cross-sectional 
studies measure prevalent rather than incident cases during a specific point (snapshot) in time, 
therefore the information is not guaranteed to be predictive. Moreover, collection of information 
about risk factors was retrospective, running the risk of recall bias; recoding and deleting non-
responses can also result in bias in measurements and outcomes. In addition, the criteria used to 
define periodontal disease, MetS, and each risk factor may differ across studies and skew results 
to show stronger or weaker associations.  
 
5.3 Implications of Findings 
 As awareness of  the barriers to access to oral healthcare and its importance in 
overall health grows, dentists, physicians, and other health professionals have begun to extend 
their support for the integration of oral disease prevention strategies into chronic disease 
prevention.68,72,73 There is a strong body of evidence today suggesting that periodontitis is likely 
to increase the risk of systemic diseases, much like periodontal therapy may improve coexisting 
chronic conditions.18-60 Moreover, there is evidence to support a bidirectional relationship such 
that comorbidities may increase the risk of periodontal disease and managing comorbidities may 
improve oral health.18-60 Introducing interprofessional education to medical and dental students 
would be an important step forward in producing clinicians knowledgeable about the 
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connections between oral health and systemic diseases. By integrating oral and physical health 
care, we can help optimize optimal screening, treatment, and prevention of both periodontitis 
and  comorbidities, reducing overall morbidity and mortality. 
 
5.4 Conclusion  
In the words of former Surgeon General Regina Benjamin, oral health “supports and 
reflects” the health of the entire body and is a “gateway” to general health and well-being.18 
Proper oral health is vital to a productive and healthy life. By understanding the risk factors 
associated with systemic diseases we are able to improve the quality of our increasing longevity 
and reduce the burden of disease for current and future generations. Based on the literature, 
there is a need for population-based action to prevent periodontitis and develop improved 
models for the integration of medical and dental healthcare. This is especially important for 
disadvantaged populations—those with less education, lower incomes, and a lack of health 
insurance coverage—that suffer a disproportionate burden of metabolic syndrome, its 
associated conditions, and periodontal disease. The present study presents an overview of the 
evidence linking periodontitis with selected systemic diseases and calls for increased 
coordination between dental and medical providers to provide optimal screening, treatment, and 
prevention of both periodontitis and its comorbidities. This study’s failure to demonstrate a 
significant association between periodontal disease, MetS, and the five metabolic risk factors, 
leaves an open invitation for additional research.  
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Table 1.1 Descriptive Statistics and Odds Ratios for the Association Between Periodontal 
Disease and Participant Demographics 
Participant 
Characteristics 
PDA  
N(%)=608 
(49.38%) 
No PDA  
N(%)=501 
(50.62%) 
TotalB 
N(%)=1109 
P-value Crude OR (95% CI) 
Demographics 
   
 
Age 
    
 
30-45 236 (44.48%) 244 (55.52%) 480 (45.49%) <.0001C 1.00D 
46-65 255 (47.76%) 202 (52.24%) 457 (40.78%) 
 
1.141 (0.793-1.642) 
>65 117 (70.45%) 55 (29.55%) 172 (13.73%) 
 
2.976 (1.958-4.522) 
Gender 
    
 
Female 275 (43.77%) 279 (56.23%) 554 (50.18%) 0.001C 1.00D 
Male 333 (55.04%) 222 (44.96%) 555 (49.82%) 
 
1.573 (1.201-2.059) 
Race/Ethnicity 
   
 
Hispanic 151 (59.61%) 95 (40.59%) 246 (13.20%) 0.0001C 1.00D 
NH-White 243 (44.47%) 271 (55.53%) 514 (69.67%) 
 
1.843 (1.094-3.104) 
NH-Black 120 (64.91%) 59 (35.09%) 179 (10.01%) 
 
2.309 (1.354-3.938) 
Other 94 (56.63%) 76 (43.37%) 170 (7.12%) 
 
1.631 (0.928-2.866) 
Education 
    
 
≤ HS 127 (71.36%) 56 (68.64%) 183 (11.51%) <.0001C 3.791 (2.484-5.784) 
>HS/Some College 307 (51.80%) 240 (48.20%) 547 (50.01%) 
 
1.635 (1.261-2.120) 
>College 174 (39.66%) 205 (60.34%) 379 (38.48%) 
 
1.00D 
PIR 
   
 
<1.00 127 (65.62%) 56 (34.38%) 183 (12.23%) <.0001C 1.915 (1.218-3.011) 
≥ 1.00-4.00 273 (50.04%) 232 (49.96%) 505 (45.93%) 
 
1.00D 
>4.00 167 (43.49%) 187 (56.51%) 354 (41.85%) 
 
0.765 (0.605-0.968) 
Insurance 
    
 
Yes 458 (46.39%) 432 (53.61%) 890 (84.21%) <.0001C 1.00D 
No 150 (65.33%) 69 (34.67%) 219 (15.79%) 
 
2.177 (1.413-3.353) 
 
Abbreviations: PD, Periodontal Disease; OR, Odds Ratio; CI, Confidence Interval; NH, Non-Hispanic; HS, Highschool; PIR, Poverty to Income Ratio 
A:Row-percent 
B:Column-percent 
C:Chi-Square statistical test was used to test for association. 
D. Referent category 
*p-value highlighted in bold indicates the finding is statistically significant at α=0.05 (p< .05) 
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Table 1.2 Descriptive Statistics and Odd Ratios for the Association Between Periodontal Disease 
and Clinical Examination 
Participant 
Characteristics 
PDA  
N(%)=608 
(49.38%) 
No PDA 
N(%)=501 
(50.62%) 
TotalB 
N(%)=1109 
P-value Crude OR (95% CI) 
Clinical Information 
   
 
Body Waist Circumference, cm 
   
 
Normal 263 (48.01%) 215 (51.99%) 478 (41.42%) 0.3625C 1.00D 
Central Obesity 335 (50.17%) 278 (49.83%) 613 (58.58%) 
 
1.090 (0.892-1.333) 
Fasting Plasma Glucose, mg/dL 
   
 
< 100 210 (46.51%) 199 (53.49%) 409 (41.14%) 0.3795C 1.00D 
≥100 398 (51.39%) 302 (48.61%) 700 (58.86%) 
 
1.216 (0.754-1.959) 
Blood Pressure, mmHg 
   
 
Normal 292 (44.87%) 283 (55.13%) 575 (54.15%) 0.0035C 1.00D 
Elevated 316 (54.71%) 218 (45.29%) 534 (45.85%) 
 
1.484 (1.087-2.026) 
Triglyceride, mg/dL 
   
 
<150 447 (49.58%) 377 (50.42%) 824 (73.84%) 0.8356C 1.00D 
≥ 150 157 (48.67%) 122 (51.33%) 279 (26.16%) 
 
 0.965 (0.665-1.398) 
HDL Cholesterol 
   
 
Normal 353 (47.48%) 314 (52.53%) 667 (58.94%) 0.3532C 1.00D 
Reduced 252 (52.06%) 185 (47.94%) 437 (41.06%) 
 
1.015 (0.655-1.574) 
Metabolic Syndrome 
   
 
No 362 (48.57%) 304 (51.43%) 666 (60.19%) 0.6334C 1.00D 
Yes 236 (50.34%) 189 (49.66%) 425 (39.81%) 
 
1.074 (0.780-1.477) 
 
Abbreviations: PD, Periodontal Disease; OR, Odds Ratio; CI, Confidence Interval; NH, Non-Hispanic; PIR, Poverty to Income Ratio 
A:Row-percent 
B:Column-percent 
C:Chi-Square statistical test was used to test for association. 
D. Referent category 
*p-value highlighted in bold indicates the finding is statistically significant at α=0.05 (p< .05) 
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Table 1.3 Descriptive Statistics and Odds Ratios for the Association Between Metabolic 
Syndrome and Participant Demographics 
Participant 
Characteristics 
MetSA 
N(%)=767 
(42.88%) 
No MetSA 
N(%)=994 
(57.12%) 
TotalB 
N(%)=1761 
P-value 
Demographics 
    
Age 
    
30-45 171 (30.57%) 409 (69.43%) 580 (36.29%) <.0001C 
46-65 346 (45.92%) 399 (54.08%) 745 (42.94%) 
 
>65 250 (58.10%) 186 (41.90%) 436 (20.77% 
 
Gender 
    
Male 321 (38.38%) 540 (61.62%) 861 (48.06%) 0.0077C 
Female 446 (47.05%) 454 (52.95%) 900 (51.94%) 
 
Race/Ethnicity 
    
Hispanic 170 (39.99%) 228 (60.01%) 398 (37.45%) <.0001C 
NH-White 391 (45.31%) 416 (54.69%) 807 (68.48%) 
 
NH-Black 157 (43.33%) 165 (56.67%) 322 (11.38%) 
 
Other 49 (23.55%) 185 (76.45%) 234 (6.90%) 
 
Education 
    
≤ HS 188 (45.55%) 218 (54.45%) 406 (26.04%) <.0001C 
>HS/Some 
College 
430 (49.00%) 450 (51.00%) 880 (51.05%) 
 
>College 148 (31.86%) 326 (64.14%) 474 (32.43%) 
 
PIR 
   
<1.00 163 (43.97%) 184 (56.03%) 347 (15.18%) 0.0047C 
≥ 1.00-4.00 395 (47.26%) 452 (52.74%) 847 (48.44%) 
 
>4.00 161 (36.97%) 291 (63.03%) 452 (36.38%) 
 
Insurance 
    
No 108 (31.48%) 231 (68.52%) 339 (16.12%) 0.0013C 
Yes 658 (45.07%) 762 (54.93%) 1420 
(83.88%) 
 
Clinical Information 
   
Periodontal Disease 
   
No 189 (38.97%) 304 (61.03%) 493 (50.73%) 0.6334 
Yes 236 (40.67%) 362 (59.33%) 598 (49.27%) 
 
 
Abbreviations: MetS, Metabolic Syndrome; NH, Non-Hispanic; HS, Highschool; PIR, Poverty to Income Ratio 
A:Row-percent 
B:Column-percent 
C:Chi-Square statistical test was used to test for association. 
*p-value highlighted in bold indicates the finding is statistically significant at α=0.05 (p< .05) 
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Table 2.1 Adjusted Odds Ratios for the Associations Between Periodontal Disease and Body 
Waist Circumference, Fasting Plasma Glucose, Blood Pressure, Triglycerides, HDL Cholesterol, 
and MetS 
Participant Characteristics Adjusted OR (95% CI) 
Body Waist Circumference, cm (Model 1) 
Normal 1.00A 
Central Obesity 1.045 (0.791-1.379) 
Fasting Plasma Glucose, mg/Dl (Model 2) 
< 100 1.00A 
≥100 0.895 (0.522-1.534) 
Blood Pressure, mmHg (Model 3) 
Normal 1.00A 
Elevated 1.172 (0.821-1.674) 
Triglyceride, mg/Dl (Model 4) 
<150 1.00A 
≥ 150 0.835 (0.550-1.269) 
HDL Cholesterol (Model 5) 
Normal 1.00A 
Reduced 0.984 (0.571-1.697) 
Metabolic Syndrome (Model 6) 
No 1.00A 
Yes 0.885 (0.607-1.288) 
 
Abbreviations: OR. Odds Ratio; CI, Confidence Interval 
**Adjusted model 1 included the following covariates: Age, Race, Gender, Education PIR, Insurance, and Body Waist Circumference 
**Adjusted model 2 included the following covariates: Age, Race, Gender, Education PIR, Insurance, and Fasting Plasma Glucose 
**Adjusted model 3 included the following covariates: Age, Race, Gender, Education PIR, Insurance, and Blood Pressure 
**Adjusted model 4 included the following covariates: Age, Race, Gender, Education PIR, Insurance, and Triglycerides 
**Adjusted model 5 included the following covariates: Age, Race, Gender, Education PIR, Insurance, and HDL Cholesterol 
**Adjusted model 6 included the following covariates: Age, Race, Gender, Education PIR, Insurance, and Metabolic Syndrome 
A:Referent Category 
 
